Takara Bio Inc. (TYO:4974)

Japan flag Japan · Delayed Price · Currency is JPY
1,142.00
0.00 (0.00%)
Jun 3, 2026, 3:30 PM JST
Market Cap137.51B +40.0%
Revenue (ttm)40.32B -10.5%
Net Income-9.60B
EPS-79.72
Shares Out 120.42M
PE Ration/a
Forward PEn/a
Dividend17.00 (1.49%)
Ex-Dividend Daten/a
Volume452,600
Open1,142.00
Previous Close1,142.00
Day's Range1,142.00 - 1,144.00
52-Week Range759.00 - 1,150.00
Beta0.44
Analystsn/a
Price Targetn/a
Earnings DateMay 13, 2026

About Takara Bio

Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and test... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,779
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4974
Full Company Profile

Financial Performance

Financial Statements